List of works by Gregory J Dore

'I didn't want to let it go too far.' The decisions and experiences of people who inject drugs who received a liver disease assessment as part of a liver health promotion campaign: The LiveRLife study.

scientific article

A comparison of seminal hepatitis C virus (HCV) RNA levels during recent and chronic HCV infection in HIV-infected and HIV-uninfected individuals

scientific article

A latent class approach to identify multi-risk profiles associated with phylogenetic clustering of recent hepatitis C virus infection in Australia and New Zealand from 2004 to 2015

article

A molecular transmission network of recent hepatitis C infection in people with and without HIV: Implications for targeted treatment strategies

scientific article published on 24 November 2016

A prospective study of hepatitis C incidence in Australian prisoners

scientific article published on 15 July 2014

A randomized trial of combination hepatitis B therapy in HIV/HBV coinfected antiretroviral naïve individuals in Thailand

scientific article published in October 2008

A systematic, deep sequencing-based methodology for identification of mixed-genotype hepatitis C virus infections

scientific article published on 14 January 2019

A variant in the MICA gene is associated with liver fibrosis progression in chronic hepatitis C through TGF-β1 dependent mechanisms

scientific article published in Scientific Reports

Acceptability and preferences of point-of-care finger-stick whole-blood and venepuncture hepatitis C virus testing among people who inject drugs in Australia

article

Adherence to once-daily and twice-daily direct acting antiviral therapy for hepatitis C infection among people with recent injection drug use or current opioid agonist therapy

scientific article published on 02 November 2019

Adherence to response-guided pegylated interferon and ribavirin for people who inject drugs with hepatitis C virus genotype 2/3 infection: the ACTIVATE study

scientific article

Adherence to sofosbuvir and velpatasvir among people with chronic HCV infection and recent injection drug use: The SIMPLIFY study

Adherence to treatment for recently acquired hepatitis C virus (HCV) infection among injecting drug users

scientific article

Alanine aminotransferase, HCV RNA levels and pro-inflammatory and pro-fibrogenic cytokines/chemokines during acute hepatitis C virus infection

scientific article published on 24 February 2016

An enormous hepatitis B virus-related liver disease burden projected in Vietnam by 2025.

scientific article published on 7 February 2008

An expanding role for primary care providers in the treatment of hepatitis C virus infection in the community

scientific article published in December 2011

An intervention to improve HCV testing, linkage to care, and treatment among people who use drugs in Tehran, Iran: The ENHANCE study

scientific article published on 11 July 2019

Antiretroviral Use in the CEASE Cohort Study and Implications for Direct-Acting Antiviral Therapy in Human Immunodeficiency Virus/Hepatitis C Virus Coinfection

scientific article published on April 2016

Antiviral therapy for hepatitis B-related liver cancer prevention is more cost-effective than cancer screening

scientific article published on 15 February 2009

Assessing the feasibility of hepatitis C virus vaccine trials: results from the Hepatitis C Incidence and Transmission Study-community (HITS-c) vaccine preparedness study.

scientific article

Assessment and delivery of treatment for hepatitis C virus infection in an opioid substitution treatment clinic with integrated peer-based support in Newcastle, Australia

scientific article published on 17 July 2015

Assessment and treatment of hepatitis C virus infection among people who inject drugs in the opioid substitution setting: ETHOS study

scientific article published on August 2013

Association between opioid agonist therapy and testing, treatment uptake, and treatment outcomes for hepatitis C infection among people who inject drugs: A systematic review and meta-analysis

scientific article published on 24 May 2020

Association between rapid utilisation of direct hepatitis C antivirals and decline in the prevalence of viremia among people who inject drugs in Australia

article

Australia on track to achieve WHO HCV elimination targets following rapid initial DAA treatment uptake: A modelling study

article

Author Correction: Hepatitis C virus elimination: laying the foundation for achieving 2030 targets

scientific article published on 05 January 2021

Baseline factors prognostic of sustained virological response in patients with HIV-hepatitis C virus co-infection

scientific article published in July 2007

Biomarkers of inflammation, coagulation and microbial translocation in HIV/HCV co-infected patients in the SMART study

scientific article published on 8 April 2014

Breaking down the barriers to hepatitis C virus (HCV) treatment among individuals with HCV/HIV coinfection: action required at the system, provider, and patient levels

scientific article published on March 2013

Can Australia Reach the World Health Organization Hepatitis C Elimination Goal by 2025 Among Human Immunodeficiency Virus-positive Gay and Bisexual Men?

scientific article published on 01 January 2020

Can hepatitis C virus infection be eradicated in people who inject drugs?

scientific article published on 24 January 2014

Cancer incidence in people with hepatitis B or C infection: A large community-based linkage study

article

Case definitions for acute hepatitis C virus infection: a systematic review.

scientific article published on 14 July 2012

Causes of death after diagnosis of hepatitis B or hepatitis C infection: a large community-based linkage study

scientific article published on September 2006

Changes in risk behaviours during and following treatment for hepatitis C virus infection among people who inject drugs: The ACTIVATE study

scientific article published on 17 June 2017

Characteristics of drug resistant HBV in an international collaborative study of HIV-HBV-infected individuals on extended lamivudine therapy

scientific article published on April 2006

Chronic hepatitis C burden and care cascade in Australia in the era of interferon-based treatment

scientific article published on 19 May 2016

Chronic hepatitis C is associated with peripheral rather than hepatic insulin resistance.

scientific article

Clearance of hepatitis C virus after newly acquired infection in injection drug users

scientific article published on 18 August 2004

Client and staff experiences of a co-located service for hepatitis C care in opioid substitution treatment settings in New South Wales, Australia.

scientific article

Clinical experience with the treatment of hepatitis C infection in patients on opioid pharmacotherapy

scientific article published on May 2011

Clinical trial literacy among injecting drug users in Sydney, Australia: A pilot study

scientific article published on 16 April 2009

Cohort profile: the international collaboration of incident HIV and hepatitis C in injecting cohorts (InC3) study.

scientific article

Combination HBV therapy is linked to greater HBV DNA suppression in a cohort of lamivudine-experienced HIV/HBV coinfected individuals

scientific article

Commentary on Gountas et al. (2017): Time to focus on empirical evidence for HCV treatment as prevention

scientific article published on July 2017

Concomitant marked decline in prevalence of SARS-CoV-2 and other respiratory viruses among symptomatic patients following public health interventions in Australia: data from St Vincent's Hospital and associated screening clinics, Sydney, NSW

scientific article published on 25 August 2020

Continued low uptake of treatment for hepatitis C virus infection in a large community-based cohort of inner city residents.

scientific article published on 20 November 2013

Contradictory advice for people who inject drugs in the 2016 EASL Recommendations on Treatment of Hepatitis C.

scientific article published on 3 February 2017

Coordination, cooperation, and creativity within harm reduction networks in Iran: COVID-19 prevention and control among people who use drugs

scientific article published on 17 August 2020

Cost-effectiveness of Treatment for Chronic Hepatitis C Infection

scientific article published on October 15, 2003

Creating an environment for equitable access to direct-acting antiviral therapy for people who inject drugs with hepatitis C

scientific article published on 01 October 2020

Daclatasvir in combination with asunaprevir and beclabuvir for hepatitis C virus genotype 1 infection with compensated cirrhosis

scientific article published in May 2015

Daclatasvir plus peginterferon and ribavirin is noninferior to peginterferon and ribavirin alone, and reduces the duration of treatment for HCV genotype 2 or 3 infection

scientific article

Daclatasvir, sofosbuvir, and ribavirin for hepatitis C virus genotype 3 and advanced liver disease: A randomized phase III study (ALLY-3+).

scientific article published on 28 January 2016

Declining hepatitis C virus-related liver disease burden in the direct-acting antiviral therapy era in New South Wales, Australia

article

Declining incidence of hepatitis C virus infection among people who inject drugs in a Canadian setting, 1996-2012.

scientific article

Defective hepatitis B virus DNA is not associated with disease status but is reduced by polymerase mutations associated with drug resistance

scientific article published on September 2008

Defining populations and injecting parameters among people who inject drugs: Implications for the assessment of hepatitis C treatment programs

scientific article published on 26 July 2015

Delivering direct acting antiviral therapy for hepatitis C to highly marginalised and current drug injecting populations in a targeted primary health care setting

scientific article published on 3 June 2017

Delivery of treatment for hepatitis C virus infection in the primary care setting

scientific article

Demonstration of Near-Elimination of Hepatitis C Virus Among a Prison Population: The Lotus Glen Correctional Centre Hepatitis C Treatment Project

scientific article published on 01 July 2018

Depression, Anxiety, and Stress Among People With Chronic Hepatitis C Virus Infection and a History of Injecting Drug Use in New South Wales, Australia.

scientific article

Direct-acting antiviral agents for HCV infection affecting people who inject drugs

scientific article

Direct-acting antiviral treatment for hepatitis C among people who use or inject drugs: a systematic review and meta-analysis

scholarly article by Behzad Hajarizadeh et al published November 2018 in The lancet. Gastroenterology & hepatology

Disease progression during advanced fibrosis: IL28B genotype or HCV RNA levels?

scientific article published on 18 February 2014

Distribution of interferon lambda-3 gene polymorphisms in Australian patients with previously untreated genotype 1 chronic hepatitis C: Analysis from the PREDICT and CHARIOT studies

scientific article published on January 2014

Diverse impacts of the rs58542926 E167K variant in TM6SF2 on viral and metabolic liver disease phenotypes

scientific article published on 28 January 2016

Dynamics of HCV RNA levels during acute hepatitis C virus infection

scientific article

Early on-treatment viral load and baseline METAVIR score: improved prediction of sustained virological response in HCV genotype 1 patients

scientific article published on 18 April 2012

Editorial Commentary: Interferon-free Hepatitis C Treatment Efficacy From Clinical Trials Will Translate to "Real World" Outcomes

scientific article published on 6 January 2016

Effect of low-level HCV viraemia at week 24 on HCV treatment response in genotype 1 patients

scientific article published in January 2011

Effect of pegylated interferon-α-2a treatment on mental health during recent hepatitis C virus infection

scientific article published in May 2012

Effective Treatment of Injecting Drug Users With Recently Acquired Hepatitis C Virus Infection

scientific article published in January 2010

Effectiveness of needle and syringe programmes for preventing HIV transmission

article

Efficacy and Safety of Ledipasvir/Sofosbuvir With and Without Ribavirin in Patients With Chronic HCV Genotype 1 Infection Receiving Opioid Substitution Therapy: Analysis of Phase 3 ION Trials

scientific article published on 23 August 2016

Efficacy and Safety of Ombitasvir/Paritaprevir/Ritonavir and Dasabuvir With or Without Ribavirin in Patients With Chronic Hepatitis C Virus Genotype 1 Infection Receiving Opioid Substitution Therapy: A Post Hoc Analysis of 12 Clinical Trials

Efficacy and Safety of Sofosbuvir/Velpatasvir in Patients With Chronic Hepatitis C Virus Infection Receiving Opioid Substitution Therapy: Analysis of Phase 3 ASTRAL Trials

scientific article published on 23 August 2016

Efficacy and safety of ombitasvir/paritaprevir/r and dasabuvir compared to IFN-containing regimens in genotype 1 HCV patients: The MALACHITE-I/II trials

scientific article published on 27 August 2015

Efficacy and safety of sofosbuvir/velpatasvir/voxilaprevir for HCV NS5A-inhibitor experienced patients with difficult to cure characteristics

scientific article published on 05 September 2020

Efficacy of 8 Weeks of Sofosbuvir, Velpatasvir, and Voxilaprevir in Patients With Chronic HCV Infection: 2 Phase 3 Randomized Trials

scientific article published on 5 April 2017

Efficacy of response-guided directly observed pegylated interferon and self-administered ribavirin for people who inject drugs with hepatitis C virus genotype 2/3 infection: The ACTIVATE study

scientific article published on 14 June 2017

Efficacy of tenofovir disoproxil fumarate in antiretroviral therapy-naive and -experienced patients coinfected with HIV-1 and hepatitis B virus

scientific article published on 12 March 2004

Efficacy of tenofovir disoproxil fumarate/emtricitabine compared with emtricitabine alone in antiretroviral-naive HIV-HBV coinfection in Thailand

scientific article published on January 2010

Elbasvir and grazoprevir for hepatitis C virus genotype 1 infection in people with recent injecting drug use (DARLO-C): An open-label, single-arm, phase 4, multicentre trial

scientific article published on 15 March 2020

Elbasvir-Grazoprevir to Treat Hepatitis C Virus Infection in Persons Receiving Opioid Agonist Therapy: A Randomized Trial.

scientific article

Elimination of Hepatitis C Virus in Australia: Laying the Foundation.

scientific article

Elimination of hepatitis C virus infection among people who inject drugs through treatment as prevention: feasibility and future requirements

scientific article published on 31 May 2013

Empfehlungen zur Hepatitis Versorgung bei Drogenkonsumierenden

scientific article

Enhanced antiviral treatment efficacy and uptake in preventing the rising burden of hepatitis C-related liver disease and costs in Australia

scientific article

Epidemiology and natural history of HCV infection.

scientific article published on 02 July 2013

Epidemiology of hepatitis C virus infection in Australia

scientific article

Epidemiology of hepatitis C virus infection in Australia

scientific article published on 01 October 2003

Estimated uptake of hepatitis C direct-acting antiviral treatment among individuals with HIV co-infection in Australia: a retrospective cohort study

scientific article published on 30 March 2020

Estimates and projections of hepatitis B-related hepatocellular carcinoma in Australia among people born in Asia-Pacific countries

scientific article published on July 2007

Estimates of chronic hepatitis B virus infection in Australia, 2000.

scientific article

Estimating the Consensus hepatitis C Cascade of Care among people who inject drugs in Australia: Pre and post availability of direct acting antiviral therapy

scientific article published on 06 July 2020

Estimating the cascade of hepatitis C testing, care and treatment among people who inject drugs in Australia

scientific article published on June 2017

Estimating the cost-effectiveness of needle-syringe programs in Australia.

scientific article published on November 2012

Estimating the number of people who inject drugs in Australia

scientific article published on 29 September 2017

Estimation of stage-specific fibrosis progression rates in chronic hepatitis C virus infection: a meta-analysis and meta-regression

scientific article

Estimation of utilities for chronic hepatitis C from SF-36 scores

scientific article

Evaluation of a Hepatitis C Virus Core Antigen Assay in Plasma and Dried Blood Spot Samples

scientific article published on 26 June 2018

Evaluation of a hepatitis C virus core antigen assay from venepuncture and dried blood spot collected samples: A cohort study

scientific article published on 18 September 2019

Evaluation of the Aptima HCV Quant Dx Assay for HCV RNA detection from finger-stick capillary dried blood spot and venepuncture-collected samples

scientific article published on 25 July 2020

Evaluation of the Xpert HCV Viral Load point-of-care assay from venepuncture-collected and finger-stick capillary whole-blood samples: a cohort study

scientific article published on 21 April 2017

Evaluation of the Xpert® HCV Viral Load Fingerstick point-of-care assay.

scientific article published on 9 March 2018

Evaluation of two community-controlled peer support services for assessment and treatment of hepatitis C virus infection in opioid substitution treatment clinics: The ETHOS study, Australia

scientific article published on 24 January 2015

Excluding people who use drugs or alcohol from access to hepatitis C treatments – Is this fair, given the available data? ⬇️

scientific article published on 4 August 2015

Expanding access to prevention, care and treatment for hepatitis C virus infection among people who inject drugs.

scientific article published on 17 July 2015

Extended treatment with pegylated interferon alfa/ribavirin in patients with genotype 2/3 chronic hepatitis C who do not achieve a rapid virological response: final analysis of the randomised N-CORE trial.

scientific article

Factors associated with HBV virological breakthrough.

scientific article published on 15 September 2016

Factors associated with elevated ALT in an international HIV/HBV co-infected cohort on long-term HAART

scientific article

Factors associated with severity of hepatic fibrosis in people with chronic hepatitis C infection

scientific article published in September 2002

Factors associated with tuberculin skin test reactivity among HIV-infected people in Bangkok.

scientific article

FibroGENE: A gene-based model for staging liver fibrosis

scientific article published on 16 November 2015

Frequent hepatitis B virus rebound among HIV-hepatitis B virus-coinfected patients following antiretroviral therapy interruption

scientific article

Frequent multiple hepatitis C virus infections among injection drug users in a prison setting

scientific article published in November 2010

Further evidence of HCV sexual transmission among HIV-positive men who have sex with men: response to Danta et al.

scientific article published in October 2007

Genetics of spontaneous clearance of hepatitis C virus infection: a complex topic with much to learn.

scientific article published on 27 May 2014

Genomic characterization of hepatitis C virus transmitted founder variants with deep sequencing

scientific article published on 08 March 2019

Genomic variability of within-host hepatitis C variants in acute infection

scientific article published on 22 January 2019

Geographic Differences in Temporal Incidence Trends of Hepatitis C Virus Infection Among People Who Inject Drugs: The InC3 Collaboration

article published in 2017

Glecaprevir and pibrentasvir yield high response rates in patients with HCV genotype 1-6 without cirrhosis

scientific article published on 12 April 2017

Glecaprevir-Pibrentasvir for 8 or 12 Weeks in HCV Genotype 1 or 3 Infection

scientific article published in January 2018

Glecaprevir/pibrentasvir in patients with chronic HCV and recent drug use: An integrated analysis of 7 phase III studies

scientific article published on 24 November 2018

Global elimination of hepatitis C virus by 2030: why not?

scientific article published on 01 February 2020

Global, regional, and country-level estimates of hepatitis C infection among people who have recently injected drugs

article

HAART's first decade: success brings further challenges

scientific article published on 01 August 2006

HBV mutations in untreated HIV-HBV co-infection using genomic length sequencing

scientific article

HCV Cure and Reinfection Among People With HIV/HCV Coinfection and People Who Inject Drugs

scientific article

HCV Specific IL-21 Producing T Cells but Not IL-17A Producing T Cells Are Associated with HCV Viral Control in HIV/HCV Coinfection

scientific article

HCV avidity as a tool for detection of recent HCV infection: sensitivity depends on HCV genotype

scientific article

HCV reinfection studies and the door to vaccine development.

scientific article published on 17 July 2009

HCV-infected patients need access now to new direct-acting antiviral agents to avert liver-related deaths.

scientific article published in May 2015

HIV and hepatitis C coinfection

scientific article published on July 2008

HIV disease progression in a patient cohort treated via a clinical research network in a resource limited setting

article

HIV infection and hepatitis C virus genotype 1a are associated with phylogenetic clustering among people with recently acquired hepatitis C virus infection.

scientific article published on 26 November 2015

HIV infection is associated with higher levels of monocyte chemoattractant protein-1 and eotaxin among people with recent hepatitis C virus infection

scientific article

Harm reduction, hepatitis C and opioid pharmacotherapy: an opportunity for integrated hepatitis C virus-specific harm reduction

scientific article published in July 2007

Hepatitis B virus among injecting drug users in Sydney, Australia: prevalence, vaccination and knowledge of status

scientific article published on 4 January 2010

Hepatitis C Virus Reinfection and Spontaneous Clearance of Reinfection--the InC3 Study

scientific article

Hepatitis C Virus Treatment and Persons Who Inject Drugs

scientific article published on 01 February 2016

Hepatitis C elimination in Australia: progress and challenges

scientific article published on 19 April 2020

Hepatitis C in Australia: impact of a mass media campaign

scientific article published on 3 November 2006

Hepatitis C reinfection after successful antiviral treatment among people who inject drugs: A meta-analysis

scientific article published on 27 November 2019

Hepatitis C testing and re-testing among people attending sexual health services in Australia, and hepatitis C incidence among people with human immunodeficiency virus: analysis of national sentinel surveillance data

scientific article published in December 2017

Hepatitis C treatment as prevention: evidence, feasibility, and challenges

scientific article published on 10 November 2016

Hepatitis C treatment outcomes in Australian clinics

scientific article published on June 2012

Hepatitis C virus clearance, reinfection, and persistence, with insights from studies of injecting drug users: towards a vaccine

scientific article published on May 2012

Hepatitis C virus core antigen: A simplified treatment monitoring tool, including for post-treatment relapse

scientific article published on 11 May 2017

Hepatitis C virus elimination: laying the foundation for achieving 2030 targets

scientific article published on 30 November 2020

Hepatitis C virus incidence among injecting drug users on opioid replacement therapy

scientific article

Hepatitis C virus prevalence and outcomes among injecting drug users on opioid replacement therapy

scientific article published in July 2005

Hepatitis C virus reinfection and superinfection among treated and untreated participants with recent infection

scientific article published on 29 February 2012

Hepatitis C virus testing, liver disease assessment and direct‐acting antiviral treatment uptake and outcomes in a service for people who are homeless in Sydney, Australia: The LiveRLife homelessness study

article

Hepatitis C virus testing, liver disease assessment and treatment uptake among people who inject drugs pre- and post-universal access to direct-acting antiviral treatment in Australia: The LiveRLife study

scientific article published on 06 December 2019

Hepatitis C virus therapeutic development: in pursuit of "perfectovir".

scientific article

Hepatitis C virus treatment for prevention among people who inject drugs: Modeling treatment scale-up in the age of direct-acting antivirals

scientific article published on 26 August 2013

Hepatitis C: Enhancing treatment for hepatitis C among drug users

scientific article published on 30 November 2010

Hepatocellular carcinoma risk following direct-acting antiviral HCV therapy: A systematic review, meta-analyses, and meta-regression

scientific article published on 9 August 2017

Hepatocellular carcinoma risk with antivirals for chronic hepatitis B: no longer confounding

scientific article published on 29 September 2020

High hepatitis C treatment uptake among people with recent drug dependence in New South Wales, Australia

scientific article published on 12 September 2020

Historical Trends in the Hepatitis C Virus Epidemics in North America and Australia

scientific article published on 28 August 2016

Hospital-related morbidity in people notified with hepatitis C: a population-based record linkage study in New South Wales, Australia

scientific article published on 10 April 2010

Human Herpesvirus 8 and Protection from AIDS Dementia Complex.

scientific article published in May 2000

Hyaluronic acid levels predict increased risk of non-AIDS death in hepatitis-coinfected persons interrupting antiretroviral therapy in the SMART Study

scientific article

IFN-λ3, not IFN-λ4, likely mediates IFNL3-IFNL4 haplotype-dependent hepatic inflammation and fibrosis

scientific article published on 10 April 2017

IL28B, HLA-C, and KIR variants additively predict response to therapy in chronic hepatitis C virus infection in a European Cohort: a cross-sectional study

scientific article

ITPA genotype protects against anemia during peginterferon and ribavirin therapy but does not influence virological response

scientific article published on 25 April 2014

Identification of a novel hepatitis B virus precore/core deletion mutant in HIV/hepatitis B virus co-infected individuals

scientific article

Immunity against hepatitis C virus infection

scientific article published on 01 September 2002

Immunological dysfunction persists for 8 months following initial mild-moderate SARS-CoV-2 infection

article published in 2021

Immunological dysfunction persists for 8 months following initial mild-to-moderate SARS-CoV-2 infection

scientific article published on 13 January 2022

Immunopathogenesis of hepatic flare in HIV/hepatitis B virus (HBV)-coinfected individuals after the initiation of HBV-active antiretroviral therapy

scientific article published in April 2009

Impact of an Open Access Nationwide Treatment Model on Hepatitis C Virus Antiviral Drug Resistance

scientific article published on 06 April 2020

Impact of high-dose peginterferon alfa-2A on virological response rates in patients with hepatitis C genotype 1: a randomized controlled trial

scientific article published on October 2009

Impact of highly active antiretroviral therapy on individual AIDS-defining illness incidence and survival in Australia

scientific article published on 01 April 2002

Impact of viral hepatitis co-infection on response to antiretroviral therapy and HIV disease progression in the HIV-NAT cohort

scientific article published in May 2004

Impaired hepatitis C virus (HCV)-specific interferon-γ responses in individuals with HIV who acquire HCV infection: correlation with CD4(+) T-cell counts

scientific article published on 4 September 2012

Impaired quality of the hepatitis B virus (HBV)-specific T-cell response in human immunodeficiency virus type 1-HBV coinfection

scientific article

Importation of generic hepatitis C therapies: bridging the gap between price and access in high-income countries.

scientific article

Improvements in parameters of end-stage liver disease in patients with HIV/HBV-related cirrhosis treated with tenofovir

scientific article published on 01 January 2007

Incidence of primary hepatitis C infection and risk factors for transmission in an Australian prisoner cohort

scientific article published on 22 October 2010

Increased hepatitis C virus vaccine clinical trial literacy following a brief intervention among people who inject drugs.

scientific article

Injecting risk behaviours following treatment for hepatitis C virus infection among people who inject drugs: The Australian Trial in Acute Hepatitis C.

scientific article

Interferon Lambda 4 Genotype Is Associated With Jaundice and Elevated Aminotransferase Levels During Acute Hepatitis C Virus Infection: Findings From the InC3 Collaborative

scientific article published on January 2016

Interferon lambda 3 genotype predicts hepatitis C virus RNA levels in early acute infection among people who inject drugs: the InC(3) study

scientific article

Interferon λ 3 and 4 Genotyping Using High-Resolution Melt Curve Analysis Suitable for Multiple Clinical Sample Types.

scientific article

Interferon-λ rs12979860 genotype and liver fibrosis in viral and non-viral chronic liver disease.

scientific article

Interleukin-28B rs12979860 C allele: Protective against advanced fibrosis in chronic hepatitis C genotype 1 infection

scientific article published on January 2014

Interventions to enhance testing, linkage to care and treatment uptake for hepatitis C virus infection among people who inject drugs: A systematic review.

scientific article published on 07 August 2017

Is severe liver disease a common outcome for people with chronic hepatitis C?

scientific article

Knowledge and attitudes about treatment for hepatitis C virus infection and barriers to treatment among current injection drug users in Australia.

scientific article published in April 2005

Knowledge and barriers associated with assessment and treatment for hepatitis C virus infection among people who inject drugs

scientific article published on 21 May 2012

Late HIV presentation among AIDS cases in Australia, 1992-2001

scientific article published on 01 December 2003

Late hepatitis B and C diagnosis in relation to disease decompensation and hepatocellular carcinoma development

scientific article published on 3 July 2017

Limited naturally occurring escape in broadly neutralizing antibody epitopes in hepatitis C glycoprotein E2 and constrained sequence usage in acute infection

scientific article published on 5 January 2017

Lipopolysaccharide, immune activation, and liver abnormalities in HIV/hepatitis B virus (HBV)-coinfected individuals receiving HBV-active combination antiretroviral therapy

scientific article published on 28 February 2014

Liver cancer and hepatitis B and C in New South Wales, 1990-2002: a linkage study

scientific article

Longitudinal injecting risk behaviours among people with a history of injecting drug use in an Australian prison setting: The HITS-p study

scientific article published on 20 January 2018

Low hepatitis C virus reinfection rate despite ongoing risk following universal access to direct-acting antiviral therapy among people living with HIV

scientific article published on 01 July 2020

Low virological response and high relapse rates in hepatitis C genotype 1 patients with advanced fibrosis despite adequate therapeutic dosing

scientific article published on 16 June 2010

MBOAT7 rs641738 increases risk of liver inflammation and transition to fibrosis in chronic hepatitis C.

scientific article published on 15 September 2016

Maintenance of Th1 hepatitis C virus (HCV)-specific responses in individuals with acute HCV who achieve sustained virological clearance after treatment

scientific article published in November 2013

Management and treatment of injection drug users with hepatitis C virus (HCV) infection and HCV/human immunodeficiency virus coinfection

scientific article

Management of acute HCV infection in the era of direct-acting antiviral therapy

scientific article published on 01 July 2018

Marked improvement in survival following AIDS dementia complex in the era of highly active antiretroviral therapy

scientific article

Markers of hepatitis B infection and immunity in patients attending Aboriginal community controlled health services

scientific article published on September 2014

Maximum levels of hepatitis C virus lipoviral particles are associated with early and persistent infection

scientific article published on 25 May 2016

Mixed HCV infection and reinfection in people who inject drugs--impact on therapy

scientific article published on 17 March 2015

Modeling the impact of early antiretroviral therapy for adults coinfected with HIV and hepatitis B or C in South Africa.

scientific article published in January 2014

Modelling hepatitis C virus incidence, prevalence and long-term sequelae in Australia, 2001.

scientific article published on October 2003

Mortality in a large community-based cohort of inner-city residents in Vancouver, Canada

scientific article published on 23 May 2013

Mortality in patients with hepatitis B or hepatitis C – Authors' reply

scientific article published in The Lancet

Mortality trends among people with hepatitis B and C: a population-based linkage study, 1993-2012.

scientific article

Moving the agenda forward: the prevention and management of hepatitis C virus infection among people who inject drugs.

scientific article published in August 2013

Moving towards hepatitis C micro-elimination among people living with HIV in Australia: the CEASE study

scientific article published on 04 October 2019

NS5A resistance-associated substitutions in patients with genotype 1 hepatitis C virus: Prevalence and effect on treatment outcome

scientific article published on 17 January 2017

Natural history models for hepatitis C-related liver disease: different disease progression parameters for different settings.

scientific article published on October 2003

Natural history of hepatitis C virus infection in HIV-infected individuals and the impact of HIV in the era of highly active antiretroviral therapy: a meta-analysis

scientific article published on October 2008

Naturally occurring dominant drug resistance mutations occur infrequently in the setting of recently acquired hepatitis C.

scientific article

Negotiating better discounts for DAA therapy is critical to achieve HCV elimination by 2030

scientific article published on 12 April 2017

No increase in hepatitis B virus (HBV)-specific CD8+ T cells in patients with HIV-1-HBV coinfections following HBV-active highly active antiretroviral therapy

scientific article

Novel Hepatitic C Virus (HCV) Diagnosis and Treatment Delivery Systems: Facilitating HCV Elimination by Thinking Outside the Clinic

scientific article published on 01 November 2020

Observations on the launch of new drugs for hepatitis C.

scientific article published in February 2018

Once-daily simeprevir (TMC435) with pegylated interferon and ribavirin in treatment-naïve genotype 1 hepatitis C: the randomized PILLAR study

scientific article

Ongoing susceptibility to hepatitis B virus infection among people who inject drugs in Sydney

scientific article published on 28 June 2012

Open-label, multicentre, single-arm trial of monthly injections of depot buprenorphine in people with opioid dependence: protocol for the CoLAB study

scientific article published on 31 July 2020

Opioid substitution therapy protects against hepatitis C virus acquisition in people who inject drugs: the HITS-c study

scientific article published on September 2014

Opportunistic disease and mortality in patients coinfected with hepatitis B or C virus in the strategic management of antiretroviral therapy (SMART) study

scientific article published in December 2008

Optimal duration of treatment for acute hepatitis C in human immunodeficiency virus-positive individuals?

scientific article published on March 2011

Outcomes from the first two years of the Australian hepatitis C surveillance strategy.

scientific article

Paritaprevir, ritonavir, ombitasvir, and dasabuvir with and without ribavirin in people with HCV genotype 1 and recent injecting drug use or receiving opioid substitution therapy

Paritaprevir, ritonavir, ombitasvir, and dasabuvir with and without ribavirin in people with HCV genotype 1 and recent injecting drug use or receiving opioid substitution therapy

Patterns and causes of suboptimal response to tenofovir-based therapy in individuals coinfected with HIV and hepatitis B virus

scientific article published on 11 January 2013

Patterns of drug, alcohol use and injection equipment sharing among people with recent injecting drug use or receiving opioid agonist treatment during and following hepatitis C virus treatment with direct-acting antiviral therapies: An international

scientific article published on 11 July 2019

Patterns of hepatitis C virus RNA levels during acute infection: the InC3 study

scientific article

Perceptions and concerns of hepatitis C reinfection following prison-wide treatment scale-up: Counterpublic health amid hepatitis C treatment as prevention efforts in the prison setting

scientific article published on 08 February 2020

Plasma interferon-gamma-inducible protein-10 (IP-10) levels during acute hepatitis C virus infection.

scientific article published on 8 May 2013

Plasma interferon-gamma-inducible protein-10 levels are associated with early, but not sustained virological response during treatment of acute or early chronic HCV infection

scientific article

Polymorphisms in STAT4 are not associated with treatment response and spontaneous clearance of hepatitis C virus in europeans

scientific article published on 27 April 2016

Poor criterion validity of self-reported hepatitis B infection and vaccination status among injecting drug users: a review

scientific article

Potential role for interleukin-28B genotype in treatment decision-making in recent hepatitis C virus infection

scientific article

Predictors and survival in hepatitis B-related hepatocellular carcinoma in New South Wales, Australia

scientific article published on 21 October 2008

Predictors of completion of a hepatitis B vaccination schedule in attendees at a primary health care centre

scientific article published on March 2007

Predictors of deferral of treatment for hepatitis C infection in Australian clinics.

scientific article published on April 2011

Prevalence and Disease Burden of HCV Coinfection in HIV Cohorts in the Asia Pacific Region: A Systematic Review and Meta-Analysis

scientific article

Prevalence and incidence of hepatitis C virus infection in men who have sex with men: a systematic review and meta-analysis

scientific article published on 17 November 2020

Prevention of hepatitis C virus in injecting drug users: a narrow window of opportunity

scientific article (publication date: March 2011)

Prioritization of HCV treatment in the direct-acting antiviral era: An economic evaluation

scientific article published on 08 February 2016

Progress Toward Hepatitis C Virus Elimination: Therapy and Implementation

scientific article published on 29 March 2020

Progress towards elimination of hepatitis C infection among people who inject drugs in Australia: The ETHOS Engage Study

scientific article published on 18 May 2020

Quality of Life and Social Functioning during Treatment of Recent Hepatitis C Infection: A Multi-Centre Prospective Cohort

scientific article

Quality of life of women living with hepatitis C.

scientific article

Quantitative HBsAg and HBeAg predict hepatitis B seroconversion after initiation of HAART in HIV-HBV coinfected individuals

scientific article

Real-world efficacy and safety of ritonavir-boosted paritaprevir, ombitasvir, dasabuvir ± ribavirin for hepatitis C genotype 1 - final results of the REV1TAL study.

scientific article published on 19 April 2017

Recomendaciones para el manejo de la infección por el virus de la hepatitis C entre usuarios de drogas por vía parenteral

Recommandations pour la prise en charge de l'infection par le virus de l'hépatite C chez les usagers de drogues par injection

scientific article published on 28 November 2015

Recommendations for the management of hepatitis C virus infection among people who inject drugs

scientific article published on 17 July 2015

Recommendations for the management of hepatitis C virus infection among people who inject drugs.

scientific article published on August 2013

Recruitment and follow-up of injecting drug users in the setting of early hepatitis C treatment: insights from the ATAHC study

scientific article published on 21 February 2007

Referral for chronic hepatitis C treatment from a drug dependency treatment setting

scientific article published on 25 October 2006

Reinfection following successful direct-acting antiviral therapy for hepatitis C infection among people who inject drugs

scientific article published on 12 March 2020

Reinfection with hepatitis C virus following sustained virological response in injection drug users

scientific article published in July 2010

Rely to Vogel et al.

scientific article published on July 2009

Reply to: "'Who killed JR': Chronic hepatitis C or alcohol use disorders?"

scientific article published on 29 December 2017

Reply to: "Direct antiviral agents and risk of HCC: Waiting for Godot".

scientific article published on 9 October 2017

Reply to: "Pitfalls in measuring temporal trends for late diagnosis of viral hepatitis"

scientific article published on 25 October 2019

Research priorities to achieve universal access to hepatitis C prevention, management and direct-acting antiviral treatment among people who inject drugs

scientific article

Response to Schmutz et al., 'Combination of tenofovir and lamivudine versus tenofovir after lamivudine failure for therapy of hepatitis B in HIV-coinfection'

scientific article published on 01 March 2007

Response to Soriano et al., 'Treatment of chronic hepatitis C virus infection: we must target the virus or liver fibrosis?'.

scientific article published in December 2003

Restrictions for Medicaid Reimbursement of Sofosbuvir for the Treatment of Hepatitis C Virus Infection in the United States

scientific article

Restrictions for reimbursement of interferon-free direct-acting antiviral drugs for HCV infection in Europe

scientific article published on 3 October 2017

Review of antenatal testing policies and practice for HIV and hepatitis C infection

scientific article published on December 2003

Risk factors for hepatocellular carcinoma in a cohort infected with hepatitis B or C.

scientific article

Risk of severe hepatotoxicity associated with antiretroviral therapy in the HIV-NAT Cohort, Thailand, 1996–2001 ⬇️

scientific article published on October 17, 2003

Robust antiviral activity of R1626, a novel nucleoside analog: a randomized, placebo-controlled study in patients with chronic hepatitis C.

scientific article published on August 2008

SARS-CoV-2 neutralizing antibodies: Longevity, breadth, and evasion by emerging viral variants

scientific article published on 06 July 2021

Safety and efficacy of glecaprevir/pibrentasvir in patients with chronic hepatitis C genotypes 1–6 receiving opioid substitution therapy

scientific article published on 06 February 2019

Screening Emergency Admissions at Risk of Chronic Hepatitis C (SEARCH) to diagnose or 're-diagnose' infections is effective in Australia

scientific article published on 01 September 2020

Sequencing of hepatitis C virus for detection of resistance to direct-acting antiviral therapy: A systematic review.

scientific article published on 22 May 2017

Sequencing of the Hepatitis C Virus: A Systematic Review.

scientific article

Sequential bottlenecks drive viral evolution in early acute hepatitis C virus infection

scientific article

Sex Discrepancies in the Protective Effect of Opioid Agonist Therapy on Incident Hepatitis C Infection

scientific article published on 01 January 2020

Short duration response-guided treatment is effective for most individuals with recent hepatitis C infection: the ATAHC II and DARE-C I studies

scientific article published on 11 February 2016

Short duration response-guided treatment is effective for most individuals with recent hepatitis C infection: the ATAHC II and DARE-C I studies.

scientific article published on 10 August 2016

Short-Duration Pan-Genotypic Therapy With Glecaprevir/Pibrentasvir for 6 Weeks Among People With Recent Hepatitis C Viral Infection

scientific article published on 24 October 2019

Simeprevir with pegylated interferon alfa 2a plus ribavirin in treatment-naive patients with chronic hepatitis C virus genotype 1 infection (QUEST-1): a phase 3, randomised, double-blind, placebo-controlled trial

scientific article published on 4 June 2014

Simplified monitoring for hepatitis C virus treatment with glecaprevir plus pibrentasvir, a randomised non-inferiority trial

scientific article published on 23 October 2019

Sofosbuvir Plus Velpatasvir Combination Therapy for Treatment-Experienced Patients With Genotype 1 or 3 Hepatitis C Virus Infection: A Randomized Trial

scientific article

Sofosbuvir and ribavirin for 6 weeks is not effective among people with recent hepatitis C virus infection: The DARE-C II study

scientific article

Sofosbuvir and velpatasvir for hepatitis C virus infection in people with recent injection drug use (SIMPLIFY): an open-label, single-arm, phase 4, multicentre trial

scientific article published on 5 January 2018

Sofosbuvir-Based Direct-Acting Antiviral Therapies for HCV in People Receiving Opioid Substitution Therapy: An Analysis of Phase 3 Studies

scientific article published on 9 February 2018

Strategies for achieving universal access to hepatitis C virus prevention and care for people who inject drugs

scientific article published on 17 July 2015

Strategies to Reduce Hepatitis C Virus Reinfection in People Who Inject Drugs

scientific article published on 01 June 2018

Surveillance for newly acquired hepatitis C in Australia

scientific article published in March 2004

Survival after diagnosis of hepatocellular carcinoma and potential impact of treatment in a hepatitis B or C infected cohort

scientific article published on 20 May 2012

Survival following hospitalization with hepatocellular carcinoma among people notified with hepatitis B or C virus in Australia (2000-2014).

scientific article published on 16 August 2017

Systematic review with meta-analysis: effectiveness of direct-acting antiviral treatment for hepatitis C in patients with hepatocellular carcinoma

scientific article published on 06 December 2019

Tell me it ain't so: patient-to-patient transmission of hepatitis C in an endoscopy clinic

article

The Influence of Hepatitis C Virus Genetic Region on Phylogenetic Clustering Analysis

scientific article published on 20 July 2015

The contribution of alcohol use disorder to decompensated cirrhosis among people with hepatitis C: An international study

scientific article published on 26 October 2017

The effect of female sex on hepatitis C incidence among people who inject drugs: results from the international multi-cohort InC3 Collaborative.

scientific article published on 24 August 2017

The effect of hepatitis C virus infection on health-related quality of life in prisoners

scientific article published on March 2006

The effect of social functioning and living arrangement on treatment intent, specialist assessment and treatment uptake for hepatitis C virus infection among people with a history of injecting drug use: The ETHOS study

scientific article published on 11 June 2015

The effects of alcohol on spontaneous clearance of acute hepatitis C virus infection in females versus males.

scientific article published on 26 October 2016

The effects of female sex, viral genotype, and IL28B genotype on spontaneous clearance of acute hepatitis C virus infection

scientific article

The epidemiology of hepatitis C in Australia: notifications, treatment uptake and liver transplantations, 1997-2006.

scientific article published on October 2009

The hepatitis C virus epidemics in key populations (including people who inject drugs, prisoners and MSM): the use of direct-acting antivirals as treatment for prevention

scientific article published in September 2015

The impact of ribavirin plasma concentration on the efficacy of the interferon-sparing regimen, sofosbuvir and ribavirin

scientific article published on 24 August 2015

The more you look, the more you find: effects of hepatitis C virus testing interval on reinfection incidence and clearance and implications for future vaccine study design

scientific article published on 29 March 2012

The removal of DAA restrictions in Europe – One step closer to eliminating HCV as a major public health threat

article

The role of re-infection in determining rates of spontaneous clearance after hepatitis C exposure

scientific article published on 26 June 2008

The role of social capital in facilitating hepatitis C treatment scale-up within a treatment-as-prevention trial in the male prison setting

scientific article published on 02 October 2020

Time to decompensated cirrhosis and hepatocellular carcinoma after an HBV or HCV notification: A population-based study

scientific article published on 8 July 2016

Time to detection of hepatitis C virus infection with the Xpert HCV Viral Load Fingerstick Point-of-Care Assay: Facilitating a more rapid time to diagnosis

scientific article published on 29 January 2020

Toll-like Receptor Expression and Signaling in Peripheral Blood Mononuclear Cells Correlate With Clinical Outcomes in Acute Hepatitis C Virus Infection

scientific article published on 9 June 2016

Transmission of hepatitis C virus infection among younger and older people who inject drugs in Vancouver, Canada

scientific article published on 25 February 2016

Treatment adherence and support for people who inject drugs taking direct-acting antiviral therapy for hepatitis C infection

scientific article published on 13 August 2019

Treatment for hepatitis C virus infection among current injection drug users in Australia

scientific article

Treatment for hepatitis C virus infection among people who inject drugs attending opioid substitution treatment and community health clinics: the ETHOS Study

scientific article published on 9 October 2015

Treatment of acute HCV infection

scientific article published on 22 March 2011

Treatment of hepatitis C virus infection among people who are actively injecting drugs: a systematic review and meta-analysis.

scientific article published on August 2013

Trends in all cause and viral liver disease-related hospitalizations in people with hepatitis B or C: a population-based linkage study

scientific article

Trends in hepatocellular carcinoma among people with HBV or HCV notification in Australia (2000-2014).

scientific article

Trends in hepatocellular carcinoma incidence and survival among people with hepatitis C: an international comparison

scientific article published on 30 November 2017

Trends in mortality after diagnosis of hepatitis B or C infection: 1992-2006.

scientific article

Trends in mortality after diagnosis of hepatitis C virus infection: an international comparison and implications for monitoring the population impact of treatment

scientific article published on 6 September 2014

Understanding facilitators and barriers of direct-acting antiviral therapy for hepatitis C virus infection in prison

scientific article published on 19 September 2018

Universal screening for hepatitis C virus infection should be linked to universal treatment access

scientific article published on 29 April 2020

Uptake of direct acting antiviral treatment for chronic hepatitis C in Australia

scientific article published on 23 December 2017

Venue-Based Networks May Underpin HCV Transmissions amongst HIV-Infected Gay and Bisexual Men.

scientific article

Viral dynamics of hepatitis B virus DNA in human immunodeficiency virus-1-hepatitis B virus coinfected individuals: similar effectiveness of lamivudine, tenofovir, or combination therapy

scientific article published on April 2009

Virological response is associated with decline in hemoglobin concentration during pegylated interferon and ribavirin therapy in hepatitis C virus genotype 1.

scientific article published in April 2011

Virological responses during treatment for recent hepatitis C virus: potential benefit for ribavirin use in HCV/HIV co-infection

scientific article published in August 2012

Vitamin D status does not predict sustained virologic response or fibrosis stage in chronic hepatitis C genotype 1 infection

scientific article published on 23 November 2012

What is killing people with hepatitis C virus infection?

scientific article

Paulina is supported by:

About Paulina

Help